Logo
x

Search category

Subscribe Now

All Posts by Date

GSK and Alector Sign $2.2B Collaboration to Develop Therapies for Neurodegenerative Diseases

GSK and Alector Sign $2.2B Collaboration to Develop Therapies for Neurodegenerative Diseases

Gan Lee Presents P-I Results of Proposed Biosimilar Insulins Aspart- Lispro and Glargine at ADA 2021

Gan Lee Presents P-I Results of Proposed Biosimilar Insulins Aspart- Lispro and Glargine at ADA 2021

Roche to Present New data of Hemlibra (emicizumab) in P-IIIb STASEY Study for Hemophilia A at ISTH 2021

Roche to Present New data of Hemlibra (emicizumab) in P-IIIb STASEY Study for Hemophilia A at ISTH 2021

Ocugen and Bharat Biotech Present Results of Covaxin in P-III Study Against COVID-19

Ocugen and Bharat Biotech Present Results of Covaxin in P-III Study Against COVID-19

Merck Amends Collaboration with NGM to Advance Novel Therapies for Retinal and CVM Diseases

Merck Amends Collaboration with NGM to Advance Novel Therapies for Retinal and CVM Diseases

Lupin's Solosec (secnidazole) Receives the US FDA's Approval for the Treatment of Trichomoniasis

Lupin's Solosec (secnidazole) Receives the US FDA's Approval for the Treatment of Trichomoniasis

Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2022 PharmaShots - All Rights Reserved.